Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 2000 Sep;83(3):248–250. doi: 10.1136/adc.83.3.248

The relationship of genotype to cognitive outcome in galactosaemia

J Shield 1, E Wadsworth 1, A MacDonald 1, A Stephenson 1, L Tyfield 1, J Holton 1, N Marlow 1
PMCID: PMC1718484  PMID: 10952646

Abstract

AIMS—To evaluate the cognitive outcome of a cohort of children with galactosaemia in relation to genotype.
METHODS—The cohort was drawn from children notified to the British Paediatric Surveillance Unit galactosaemia study which ran from 1988 to 1990. Cognitive outcome was assessed using the Wechsler Intelligence Scale for Children or the Wechsler Preschool and Primary Scale of Intelligence. Parents completed a questionnaire detailing educational status, and the attending paediatrician returned a questionnaire regarding age at diagnosis and biochemical outcome over the previous two years.
RESULTS—A total of 45 children were genotyped: 30 were homoallelic for the Q188R mutation, the remainder being heteroallelic for Q188R with K285N (n = 4), L195P (n = 4), or other mutations (n = 7). Psychometric evaluation was available in 34 cases: mean full scale IQ was 79, verbal quotient 79, and performance quotient 82. Genotype was not related to galactose-1-phosphate (Gal-1-P) concentrations. However, children homoallelic for the Q188R mutation had significantly lower IQ scores than those who were heteroallelic (73.6 v 94.8). This difference was independent of social and demographic influences and Gal-1-P concentrations over the previous two years.
CONCLUSIONS—In children with galactosaemia, cognitive outcome appears to relate to genotype rather than metabolic control, as reflected by Gal-1-P concentrations. The value of measuring Gal-1-P concentrations routinely once successfully established on a galactosaemia diet is questionable as concentrations do not appear to affect outcome. In the UK population, homozygosity for the Q188R mutation is invariably associated with a poor outcome, and there is evidence that variability in neurocognitive outcome is at least part dependent on allelic heterogeneity.



Full Text

The Full Text of this article is available as a PDF (79.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Cleary M. A., Heptinstall L. E., Wraith J. E., Walter J. H. Galactosaemia: relationship of IQ to biochemical control and genotype. J Inherit Metab Dis. 1995;18(2):151–152. doi: 10.1007/BF00711752. [DOI] [PubMed] [Google Scholar]
  2. Elsas L. J., Langley S., Steele E., Evinger J., Fridovich-Keil J. L., Brown A., Singh R., Fernhoff P., Hjelm L. N., Dembure P. P. Galactosemia: a strategy to identify new biochemical phenotypes and molecular genotypes. Am J Hum Genet. 1995 Mar;56(3):630–639. [PMC free article] [PubMed] [Google Scholar]
  3. Geeganage S., Frey P. A. Transient kinetics of formation and reaction of the uridylyl-enzyme form of galactose-1-P uridylyltransferase and its Q168R-variant: insight into the molecular basis of galactosemia. Biochemistry. 1998 Oct 13;37(41):14500–14507. doi: 10.1021/bi9815546. [DOI] [PubMed] [Google Scholar]
  4. Greber-Platzer S., Guldberg P., Scheibenreiter S., Item C., Schuller E., Patel N., Strobl W. Molecular heterogeneity of classical and Duarte galactosemia: mutation analysis by denaturing gradient gel electrophoresis. Hum Mutat. 1997;10(1):49–57. doi: 10.1002/(SICI)1098-1004(1997)10:1<49::AID-HUMU7>3.0.CO;2-H. [DOI] [PubMed] [Google Scholar]
  5. Honeyman M. M., Green A., Holton J. B., Leonard J. V. Galactosaemia: results of the British Paediatric Surveillance Unit Study, 1988-90. Arch Dis Child. 1993 Sep;69(3):339–341. doi: 10.1136/adc.69.3.339. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Kaufman F. R., Reichardt J. K., Ng W. G., Xu Y. K., Manis F. R., McBride-Chang C., Wolff J. A. Correlation of cognitive, neurologic, and ovarian outcome with the Q188R mutation of the galactose-1-phosphate uridyltransferase gene. J Pediatr. 1994 Aug;125(2):225–227. doi: 10.1016/s0022-3476(94)70197-0. [DOI] [PubMed] [Google Scholar]
  7. Leslie N. D., Yager K. L., McNamara P. D., Segal S. A mouse model of galactose-1-phosphate uridyl transferase deficiency. Biochem Mol Med. 1996 Oct;59(1):7–12. doi: 10.1006/bmme.1996.0057. [DOI] [PubMed] [Google Scholar]
  8. Reichardt J. K., Packman S., Woo S. L. Molecular characterization of two galactosemia mutations: correlation of mutations with highly conserved domains in galactose-1-phosphate uridyl transferase. Am J Hum Genet. 1991 Oct;49(4):860–867. [PMC free article] [PubMed] [Google Scholar]
  9. Schweitzer S., Shin Y., Jakobs C., Brodehl J. Long-term outcome in 134 patients with galactosaemia. Eur J Pediatr. 1993 Jan;152(1):36–43. doi: 10.1007/BF02072514. [DOI] [PubMed] [Google Scholar]
  10. Smith R. Osteogenesis imperfecta, non-accidental injury, and temporary brittle bone disease. Arch Dis Child. 1995 Feb;72(2):169–176. doi: 10.1136/adc.72.2.169. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Sommer M., Gathof B. S., Podskarbi T., Giugliani R., Kleinlein B., Shin Y. S. Mutations in the galactose-1-phosphate uridyltransferase gene of two families with mild galactosaemia variants. J Inherit Metab Dis. 1995;18(5):567–576. doi: 10.1007/BF02436001. [DOI] [PubMed] [Google Scholar]
  12. Tyfield L., Reichardt J., Fridovich-Keil J., Croke D. T., Elsas L. J., 2nd, Strobl W., Kozak L., Coskun T., Novelli G., Okano Y. Classical galactosemia and mutations at the galactose-1-phosphate uridyl transferase (GALT) gene. Hum Mutat. 1999;13(6):417–430. doi: 10.1002/(SICI)1098-1004(1999)13:6<417::AID-HUMU1>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
  13. Waggoner D. D., Buist N. R., Donnell G. N. Long-term prognosis in galactosaemia: results of a survey of 350 cases. J Inherit Metab Dis. 1990;13(6):802–818. doi: 10.1007/BF01800204. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES